CBPD-409 is a highly мощный, селективный and orally bioavailable PROTAC degrader of CBP/p300. CBPD-409 induces robust CBP/p300 degradation with DC50 0.2-0.4 nM and displays strong antiproliferative effects с IC50 1.2-2.0 nM in the VCaP, LNCaP, and 22Rvl AR+ prostatcancer клетка lines.
CBPD-409 is a highly potent, selective and orally bioavailable PROTAC degrader of CBP/p300. CBPD-409 induces robust CBP/p300 degradation with DC50 0.2-0.4 nM and displays strong antiproliferative effects with IC50 1.2-2.0 nM in the VCaP, LNCaP, and 22Rvl AR+ prostatcancer cell lines.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.